IDT’s good start with new strategy
Pharmaceutical and medicinal cannabis manufacturer IDT Australia has reported a sales turnaround with revenues of $3 million in Q1FY24, up 300 percent on the previous corresponding period. The company told investors it has secured a further $2.1 million in new contracts in October with $4.2 million in contracts at the approval stage. The company’s sales…